S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 15, 2012
June 16, 2026
de0d3a32-bb96-4225-a321-61404f42a946
Related Documents
S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Guidance DocumentJune 7, 2012Center for Drug Evaluation and Research
E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)
Guidance DocumentJanuary 29, 2013Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.